Gamida Cell Ltd. announced that the company will host a conference call and live audio webcast on Tuesday, February 25, 2020, at 8:30 a.m. ET to review its full year 2019 financial results and provide an update on the company.
BOSTON--(BUSINESS WIRE)-- Gamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious blood diseases, today announced that the company will host a conference call and live audio webcast on Tuesday, February 25, 2020, at 8:30 a.m. ET to review its full year 2019 financial results and provide an update on the company.
The webcast will be available on the “Investors” section of the Gamida Cell website at www.gamida-cell.com. To participate in the live call, please dial 866-930-5560 (domestic) or +1-409-216-0605 (international) and refer to conference ID number 7886498. A recording of the webcast will be available approximately two hours after the event, for approximately 30 days.
About Gamida Cell
Gamida Cell is an advanced cell therapy company committed to cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need. For additional information, please visit www.gamida-cell.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200219005042/en/
Contacts
Jaren Irene Madden
jaren@gamida-cell.com
1-617-286-6264
Max Stendahl (media)
max@tenbridgecommunications.com
508-277-8117
Source: Gamida Cell Ltd.
View this news release online at:
http://www.businesswire.com/news/home/20200219005042/en